Startseite Comparison of Proteolytic Enzymes and Glutathione S-Transferase Levels in Non-Heart-Beating Donors' (NHBD) Kidney Perfusates
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Comparison of Proteolytic Enzymes and Glutathione S-Transferase Levels in Non-Heart-Beating Donors' (NHBD) Kidney Perfusates

  • Shlokarth Balupuri , David Talbot , Mohamed El-Sheikh , Chris Snowden , Derek M. Manas , John Kirby und David Mantle
Veröffentlicht/Copyright: 1. Juni 2005
Veröffentlichen auch Sie bei De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 38 Heft 11

Abstract

In order to identify biochemical markers of kidney damage prior to transplantation, we determined the levels of activity of a range of proteolytic enzymes in kidney perfusate samples from non-heart-beating donor (NHBD) cases. Urinary protease activities have been described as indices of kidney damage in renal disease; their potential as markers of tissue damage in kidneys before transplantation has not been assessed. In an attempt to identify additional/ improved biochemical markers, the present study compared the levels of total glutathione S-transferase (GST) with corresponding levels of several proteolytic enzymes in perfusate fluid from machine perfused NHBD kidneys. Proteases were selected to represent factors that may influence enzyme efflux, such as intracellular localization or molecular size.

Methods: Perfusate samples were obtained over an 8-hour period from machine-preserved NHBD kidneys. Protease activities in these samples were determined by fluorometric assays and comparison made with total GST activity. Individual proteases were analysed in the transplanted and non-transplanted kidney groups (discarded on the basis of other viability parameters).

Results: A correlation between protease activity and total GST was obtained for only leucyl- and pyroglutamyl aminopeptidase. Furthermore, in the transplanted group, it was possible to set nominal upper limits of activity for alanyl-arginyl- and dipeptidyl IV-aminopeptidase (AP). In the non-transplanted kidney group protease levels were increased above “normal” upper limits for the same enzyme types. By the use of alanyl AP it was possible to discriminate 75% of unsuitable kidneys discarded by the use of other criteria.

Conclusion: The lack of correlation between total GST and protease activity for most of the enzymes investigated and alanyl AP levels in perfusate samples could be related to differences in cellular localisation, suggesting that assays of alanyl AP may give complimentary biochemical information relating to kidney tissue damage. Quantification of alanyl AP in machine perfusate samples may be a valuable additional independent biomarker of tissue damage.

:
Published Online: 2005-06-01
Published in Print: 2000-11-12

Copyright © 2000 by Walter de Gruyter GmbH & Co. KG

Artikel in diesem Heft

  1. European Meeting on Biomarkers of Organ Damage and Dysfunction Selected Papers from the Meeting Held in Cambridge, UK April 3rd-7th, 2000
  2. Kidney Retrieval Conditions Influence Damage to Renal Medulla: Evaluation by Proton Nuclear Magnetic Resonance (NMR) Spectroscopy
  3. Citrate, Acetate and Renal Medullary Osmolyte Excretion in Urine as Predictor of Renal Changes after Cold Ischaemia and Transplantation
  4. Comparison of Proteolytic Enzymes and Glutathione S-Transferase Levels in Non-Heart-Beating Donors' (NHBD) Kidney Perfusates
  5. Assessment of Non-Heart-Beating Donor (NHBD) Kidneys for Viability on Machine Perfusion
  6. Low Levels of Urinary Albumin Excretion Are Associated with Cardiovascular Risk Factors in the General Population
  7. Evaluation of a Fully Automated Assay to Measure C-Telopeptide of Type I Collagen in Serum
  8. Bone Turnover Markers and Estradiol Level in Postmenopausal Women
  9. External Quality Assessment of Bone Metabolism Marker Assays. Initial Experiences in a UK NEQAS Programme
  10. The Monoethylglycinexylidide (MEGX) Test as a Marker of Hepatic Dysfunction in Septic Patients with Pneumonia
  11. Transforming Growth Factor-β1 as a Surrogate Marker of Hepatic Dysfunction in Chronic Liver Diseases
  12. A New Approach to the Evaluation of Liver Graft Function by Nuclear Magnetic Resonance Spectroscopy. A Comparative Study between Euro-Collins and University of Wisconsin Solutions
  13. Metallothionein and Heat Shock Protein Expression during Acute Liver Injury and Regeneration in Rats
  14. Biochemical Evaluation of Patients with Acute Pancreatitis
  15. Screening for Acute Myocardial Injury: Creatine Kinase Is Comparable to Myoglobin
  16. Different Time Frames for the Occurrence of Elevated Levels of Cardiac Troponin T and C-Reactive Protein in Patients with Acute Myocardial Infarction
  17. Determination of Decision Limits for ACS:Systems Cardiac Troponin I
  18. Stability of Cardiac Troponins and CK-MB Mass Isoenzyme
  19. Cytokines as Plasma Markers of Abdominal Aortic Aneurysm
  20. The Early Fall in Levels of S-100 β in Traumatic Brain Injury
  21. Protein S-100β in Brain and Serum after Deep Hypothermic Circulatory Arrest in Rabbits: Relationship to Perivascular Astrocytic Swelling
  22. The Effect of Continuous Treatment with Sodium Nitroprusside on the Serum Kinetics of the Brain Marker Protein S-100β in Neonates Undergoing Corrective Cardiac Surgery by Means of Hypothermic Cardiopulmonary Bypass
  23. Differentiated Therapy with Prostaglandin E1 (Alprostadil) after Orthotopic Liver Transplantation: the Usefulness of Procalcitonin (PCT) and Hepatic Artery Resistive Index (RI) for the Evaluation of Early Graft Function and Clinical Course
  24. The Postoperative Course of γ-Glutamyl Transpeptidase – a Marker of Cytomegalovirus (CMV) Replication Risk?
  25. TNF-α and Its Receptors Mediate Graft Rejection and Loss after Liver Transplantation
  26. Impact of Ig-Therasorb® Immunoapheresis on Stability of Xenogeneic Ex Vivo Porcine Liver Perfusion – Value of Aminotransferases and Flow Rates for the Assessment of Metabolic Graft Viability
  27. The Effect of Human Organ Preservation and Albumin Flush Solution on In Vitro Cell Metabolic Activity
  28. An Ex Vivo Model of Tolerance vs. Rejection: Comparison of Different Signal Transducers and Activators of Transcription, STAT1, STAT4, STAT5 and STAT6
  29. Detection of Cytomegalovirus (CMV) Antigens in Kidney Biopsies and Transplant Nephrectomies as a Marker for Renal Graft Dysfunction
  30. Comparison of Five Cyclosporin Immunoassays with HPLC
  31. In Vitro Pentamer Formation as a Biomarker of Tacrolimus-Related Immunosuppressive Activity after Liver Transplantation
  32. Pharmacodynamic Monitoring of Mycophenolate Mofetil
Heruntergeladen am 18.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2000.163/html?lang=de
Button zum nach oben scrollen